These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9332078)

  • 1. [New generation of oral contraceptives and the cardiovascular effects].
    Ben-Arie A; Hagay Z
    Harefuah; 1997 Aug; 133(3-4):111-5. PubMed ID: 9332078
    [No Abstract]   [Full Text] [Related]  

  • 2. [Should the use of oral contraceptives be stopped by the age of 40?].
    Halttunen M
    Duodecim; 2002; 118(16):1629-30. PubMed ID: 12271939
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic and vascular consequences of hormonal contraception in non-diabetics].
    Basdevant A; Guy-Grand B
    Journ Annu Diabetol Hotel Dieu; 1983; ():223-37. PubMed ID: 6358613
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical and metabolic effects of oral contraceptives].
    Vázquez Hernández L; Téllez Martínez J; Hicks Gómez JJ
    Ginecol Obstet Mex; 2000 Feb; 68():64-9. PubMed ID: 10774107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of oral contraceptives on blood coagulation].
    Rasović N; Rolović Z; Doder M; Tucović Z
    Srp Arh Celok Lek; 1971; 99(7):493-500. PubMed ID: 5146127
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral contraceptives: technical and safety aspects.
    WHO Offset Publ; 1982; (64):1-45. PubMed ID: 7102094
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral contraceptives--risk factors for cardiovascular events--chance association or causal relation?].
    Marmot M; Heinemann L
    Z Arztl Fortbild (Jena); 1988; 82(2):57-63. PubMed ID: 3284213
    [No Abstract]   [Full Text] [Related]  

  • 8. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of clotting factors to dosage levels of estrogen and progestogen-like combinations.
    Banks AL; Rutherford RN; Coburn WA; Welsh RL
    Int J Fertil; 1966; 11(3):277-80. PubMed ID: 5967993
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultra-low-dose oral contraceptives: are they right for your patient?
    Thorneycroft IH; Cariati SL
    Medscape Womens Health; 2001 Aug; 6(4):3. PubMed ID: 11811135
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood coagulation during treatment with oral contraceptives].
    Bailo U; Finzi C
    Minerva Ginecol; 1968 Dec; 20(23):1879-84. PubMed ID: 5734792
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations for the prescription of oral contraceptives.
    Györváry V; Némedi L
    Ther Hung; 1977; 25(1):4-9. PubMed ID: 558662
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral contraceptives and thrombosis. Some coagulation and fibrinolysis changes].
    Gjonnaess H
    Nord Med; 1970 Nov; 84(46):1473. PubMed ID: 5479947
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality rates with oral contraception.
    N Z Med J; 1977 Dec; 86(601):525. PubMed ID: 272572
    [No Abstract]   [Full Text] [Related]  

  • 17. On oral contraceptive safety: cardiovascular problems.
    Edgren RA
    Int J Fertil; 1981; 26(4):241-4. PubMed ID: 6120903
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of oral contraceptives on blood clotting (author's transl)].
    Salahović S; Grgićević D; Pistotnik M; Flego I; Delimar N
    Lijec Vjesn; 1976 Apr; 98(4):177-80. PubMed ID: 966953
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vascular risk of oral contraceptive agents: realities and mechanisms. II. Mechanisms of vascular accidents: their prevention].
    Beaumont V; Beaumont JL
    Presse Med; 1989 Jun; 18(25):1249-53. PubMed ID: 2525774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Against continuing oral contraceptives up to age 50].
    Haramburu F
    Gynecol Obstet Fertil; 2005 Mar; 33(3):166-8. PubMed ID: 15848093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.